Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection.

Saved in:
Bibliographic Details
Title: Associations of COVID-19 vaccination with risks for post-infectious cardiovascular complications: an international cohort study in cancer patients with SARS-CoV-2 infection.
Authors: Lin EP; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Division of Thoracic Medicine, Department of Internal Medicine, School of Medicine & Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Division of Thoracic Medicine, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.; Center for Precision Health and Quantitative Sciences & Precision Medicine Research Center, Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan., Hsu CY; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA., Mishra S; Division of Hematology and Oncology, Department of Medicine, Brown University, Providence, RI 02912, USA.; Lifespan Cancer Institute at Rhode Island Hospital, Providence, RI 02912, USA., Griffiths EA; Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Segal BH; Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA., Hwang C; Division of Hematology/Oncology, Department of Internal Medicine, Henry Ford Health, Detroit, MI, 48202, USA., Singh SRK; Division of Hematology/Oncology, Department of Internal Medicine, Henry Ford Health, Detroit, MI, 48202, USA.; University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA., Balanchivadze N; Division of Hematology/Oncology, Department of Internal Medicine, Henry Ford Health, Detroit, MI, 48202, USA.; Virginia Oncology Associates, Norfolk, VA 23502, USA., Jani C; Mount Auburn Hospital, Cambridge, MA 02138, USA.; Sylvester Comprehensive Cancer Center, Miami, FL 33136, USA., Mariano MG; Mount Auburn Hospital, Cambridge, MA 02138, USA., Bhatt PS; Mount Auburn Hospital, Cambridge, MA 02138, USA., Vieira K; Lifespan Cancer Institute at Rhode Island Hospital, Providence, RI 02912, USA., Yu PP; Hartford HealthCare Cancer Institute, Hartford, CT 06102, USA., Oligino EJ; Hartford HealthCare Cancer Institute, Hartford, CT 06102, USA., Wise-Draper T; University of Cincinnati Cancer Center, Cincinnati, OH 45267, USA., Ferrara EK; University of Cincinnati Cancer Center, Cincinnati, OH 45267, USA., McKay RR; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA., Nonato TK; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA., Labaki C; Lank Center for Genitourinary (GU) Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Saad E; Lank Center for Genitourinary (GU) Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Saliby RM; Lank Center for Genitourinary (GU) Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Morgans AK; Lank Center for Genitourinary (GU) Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Nohria A; Cardio-Oncology Program, Brigham and Women's Hospital, Boston, MA 02115, USA., Puc M; Virtua Health, Marlton, NJ 08053, USA., Accordino MK; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, NY 10032, USA., Bodin BE; Herbert Irving Comprehensive Cancer Center at Columbia University, New York, NY 10032, USA., Nanchal R; Medical College of Wisconsin, Milwaukee, WI 53226, USA., Singh H; Medical College of Wisconsin, Milwaukee, WI 53226, USA., Berg S; Lank Center for Genitourinary (GU) Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.; Loyola University Medical Center, Maywood, IL 60153, USA., Mavromatis B; UPMC Western Maryland, Cumberland, MD 2150, USA., McManus HD; Division of Medical Oncology, Department of Medicine, Duke University, Durham, NC, USA., Halabi S; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC 27710, USA., Choueiri TK; Lank Center for Genitourinary (GU) Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA., Warner JL; Division of Hematology and Oncology, Department of Medicine, Brown University, Providence, RI 02912, USA.; Lifespan Cancer Institute at Rhode Island Hospital, Providence, RI 02912, USA., Shyr Y; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Center for Quantitative Sciences, Vanderbilt University Medical Center, Nashville, TN 37232, USA.; Graduate Institute of Data Science, College of Management, Taipei Medical University, Taipei, Taiwan.
Corporate Authors: COVID-19 and Cancer Consortium
Source: Lancet regional health. Americas [Lancet Reg Health Am] 2025 Mar 06; Vol. 44, pp. 101038. Date of Electronic Publication: 2025 Mar 06 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9918232503006676 Publication Model: eCollection Cited Medium: Internet ISSN: 2667-193X (Electronic) Linking ISSN: 2667193X NLM ISO Abbreviation: Lancet Reg Health Am Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2667-193X
DOI:10.1016/j.lana.2025.101038